James M. Hindman - Net Worth and Insider Trading

James M. Hindman Net Worth

The estimated net worth of James M. Hindman is at least $7 Million dollars as of 2024-06-05. James M. Hindman is the EVP, Finance & Bus. Dev., CFO of Allergan PLC and owns about 36,574 shares of Allergan PLC (AGN) stock worth over $7 Million. Details can be seen in James M. Hindman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James M. Hindman has not made any transactions after 2014-08-18 and currently still holds the listed stock(s).

Transaction Summary of James M. Hindman

James M. Hindman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James M. Hindman owns 5 companies in total, including Urovant Sciences Ltd (UROV) , Millendo Therapeutics Inc (MLND) , and Accuray Inc (ARAY) among others .

Click here to see the complete history of James M. Hindman’s form 4 insider trades.

Insider Ownership Summary of James M. Hindman

Ticker	Comapny	Transaction Date	Type of Owner
UROV	Urovant Sciences Ltd	2020-07-21	director
MLND	Millendo Therapeutics Inc	2020-06-22	director
ARAY	Accuray Inc	2019-09-06	director
		2019-05-30	director
		2018-12-07	director

James M. Hindman Latest Holdings Summary

James M. Hindman currently owns a total of 1 stock. James M. Hindman owns 36,574 shares of Allergan PLC (AGN) as of August 18, 2014, with a value of $7 Million.

Latest Holdings of James M. Hindman

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
AGN	Allergan PLC	2014-08-18	36,574	193.02	7,059,513

Holding Weightings of James M. Hindman

James M. Hindman Form 4 Trading Tracker

According to the SEC Form 4 filings, James M. Hindman has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 0 shares on August 18, 2014, which brought James M. Hindman around $0.

Insider Trading History of James M. Hindman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James M. Hindman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James M. Hindman Ownership Network

Ownership Network List of James M. Hindman

No Data

Ownership Network Relation of James M. Hindman

James M. Hindman Owned Company Details

What does Urovant Sciences Ltd do?

Who are the key executives at Urovant Sciences Ltd?

James M. Hindman is the director of Urovant Sciences Ltd. Other key executives at Urovant Sciences Ltd include SVP & Commercial & USI Walt Johnston , CMO/Urovant Sciences & Inc. Haag-molkenteller Cornelia , and PFO;CFO/Urovant Sciences & Inc. Ajay Bansal .

Urovant Sciences Ltd (UROV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Urovant Sciences Ltd (UROV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Urovant Sciences Ltd (UROV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Urovant Sciences Ltd (UROV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Urovant Sciences Ltd Insider Transactions

No Available Data

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

James M. Hindman is the director of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include General Counsel and Secretary Tamara L Joseph , Chief Financial Officer Arcudi Iii Louis J , and director & President and CEO Julia C. Owens .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millendo Therapeutics Inc Insider Transactions

No Available Data

What does Accuray Inc do?

Who are the key executives at Accuray Inc?

James M. Hindman is the director of Accuray Inc. Other key executives at Accuray Inc include Senior VP Global Operations Michael Hoge , VP & Corporate Controller Gina Corradetti , and SVP Chief Financial Officer Ali Pervaiz .

Accuray Inc (ARAY) Insider Trades Summary

Over the past 18 months, James M. Hindman made no insider transaction in Accuray Inc (ARAY). Other recent insider transactions involving Accuray Inc (ARAY) include a net sale of 31,767 shares made by Ali Pervaiz , a net sale of 137,932 shares made by Suzanne C Winter , and a net sale of 39,556 shares made by Michael Hoge .

In summary, during the past 3 months, insiders sold 0 shares of Accuray Inc (ARAY) in total and bought 100,000 shares, with a net purchase of 100,000 shares. During the past 18 months, 323,628 shares of Accuray Inc (ARAY) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 223,628 shares.

Accuray Inc (ARAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Accuray Inc Insider Transactions

No Available Data

What does Sienna Biopharmaceuticals Inc do?

Who are the key executives at Sienna Biopharmaceuticals Inc?

James M. Hindman is the director of Sienna Biopharmaceuticals Inc. Other key executives at Sienna Biopharmaceuticals Inc include Chief Financial Officer Alexander Azoy , Chief Medical Officer Paul F. Lizzul , and director & President & CEO Iii Frederick Beddingfield .

Sienna Biopharmaceuticals Inc (SNNAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sienna Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

James M. Hindman is the director of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include Corporate Controller Justin Trojanowski , VP of Strategy and Finance Nicholas Maestas , and 10 percent owner Versant Side Fund Iv, L.p. .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tempest Therapeutics Inc (TPST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tempest Therapeutics Inc Insider Transactions

No Available Data

James M. Hindman Mailing Address

Above is the net worth, insider trading, and ownership report for James M. Hindman. You might contact James M. Hindman via mailing address: 2525 Dupont Drive, Irvine Ca 92612.

Discussions on James M. Hindman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.